Tuberculosis bacteria under microscope
1
2
3
4
5

The 2017 Union Conference is in Guadalajaro, Mexico, October 11-14. Come say hello and hear about exciting research underway in India!

ID Clinical Minute is now available for Continuing Medication Education Credit! 

C-TRIUMPH nested study begins to see if stringent response antigen is enhanced while treating drug-susceptible TB using the first-line anti-TB regimen.

New study in Pune, India, aims to identify the profile of TB antibodies between mothers and infants, and to see if the presence of antibodies lowers risk of infant infection.


Learn about CCGHE's work to improve infectious disease prevention & treatment around the world.

Case Review: 62 yo, previously healthy male from Cape Verde; presented to PCP in Dec 2015; abscesses on chest, back & axilla.

CCGHE is keeping an eye on Zika among pregnant women, which is transmitted by mosquitoes & can cause devastating birth defects.

In a multi-country study, we are assessing the accuracy of the BD MAX rapid MDR-TB assay to detect rifampin and isoniazid resistance.

Photo of Dr. Bob Bollinger

The NIH Fogarty International Center announced today the appointment of CCGHE Founding Director Dr. Robert C. Bollinger to the Center's Advisory...

Dr. Bob Bollinger talks with the NIH Fogarty Center about development of the emocha mobile health platform.

. . . "We still do have a lot of people on protease inhibitors in this country," Chida told MedPage Today. "Data to prove the safety and sustain...

Dr. Natasha Chida

MedPage Today caught up with Dr. Natasha Chida at IDWeek 2017

Issues will be published bimonthly and CME will be available through ACCME

Photo of Dr. Jeffrey Tornheim

His research explores whether 2 MDR-TB drug susceptibility tests using WGS & MIC can yield options for individualized treament.